Charite University, Berlin, Germany
Berlin, 13353, Germany
NCT Number: NCT03200314
A prospective, observational study will be performed measuring recirculation of blood through a veno-venous Extracoporeal Membrane Oxygenation (vvECMO) in patients with acute respiratory distress syndrome (ARDS) on vvECMO. ECMO blood flow will be adjusted with respect to recirculation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Berlin, 13353, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound based measurments of blood recirculating through the vvECMO circuit.
Time frame: Once within first week after ICU admission during 4 hours
Amount of ECMO blood flow recirculating through the vvECMO circuit
Time frame: Once within first week after ICU admission during 4 hours
Reduction of vvECMO blood flow if a significant recirculation can be measured
Time frame: Once within first week after ICU admission during 4 hours
Change in arterial blood oygen content after reduction of vvECMO blood flow
Charite University, Berlin, Germany
Other
Measurment of Blood Recirculation and Adjustment of vvECMO Blood Flow During Veno-venous Extracoporeal Membrane Oxygenation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03764319
ARDS, Acute Lung Injury
Vienna, Austria
View Trial DetailsNCT05531032
ARDS, COVID-19 Pneumonia
Vienna, Austria
View Trial DetailsNCT05341687
ARDS, Acute Lung Injury
Nancy, France
View Trial DetailsNCT04405973
ARDS, COVID-19
Freiburg im Breisgau, Germany
View Trial Details